Rheumatoid Arthritis Flashcards

1
Q

what is rheumatoid arthritis (RA)?

A

Autoimmune, systemic, inflammatory disease.
- Characterised by chronic, persistent synovial inflammation which leads to destruction of articular cartilage and bone
- Causes decline in joint function and progressive disability if untreated
- Bone loss and cartilage loss is irreparable – no recovery, so important to treat patients early

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

is RA considered fully autoimmune?

A

A causal antigen has not yet been discovered – so is it definitely autoimmune or is it autoinflammatory?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

when is the typical onset of RA?

A

Typical onset is between 40 and 60 years old, however it can begin at any age – not really an age releated disease. If before 18 – JIA (juvenile idiopathic arthritis), later diagnosed as RA

Between 0.5-1% of adults have RA (Smolen et al., 2016). The severity is highly variable
- common autoimmune disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what joints can RA affect?

A

RA can affect any joint but usually initially affects the MCP, PIP and MTP joints, sometimes progressing to the wrists, ankles and knees. - Does not usually affect the axial skeleton (spine).
-Characterised by a symmetrical pattern of joint involvement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the common symptomatic features of RA?

A
  • a symmetrical polyarthritis with pain and swelling affecting the small joints of the hands and feet
  • morning stiffness in and around the affected joints which improves with activity and frequently report debilitating fatigue
  • swelling due to oedema, which can be dispersed with movement
  • fatigue is the most difficult symptom to model and treat - caused by continuous autoinflammatory response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the key laboratory features of RA?

A

Increased level of acute phase reactants (e.g. C reactive protein (CRP) )

Increased level of erythrocyte sedimentation rate (ESR))

Presence of autoantibodies such as Rheumatoid Factor (RF) and Anti-Citrillinated Protein Autoantibodies (ACPA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the normal structure of a joint?

A

At ends of bone is articular cartilage – crucial for joint function
- glycoprotein rich, so can absorb water
- Smooth tissue – enables smooth movement of join
- Cartilage surfaces are lubricated by synovial fluid, produced by synovial membrane
- This membrane is thin, comprised of fibroblasts and macrophages, producing lubricin – couple of cells thick

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how are joints altered in RA?

A

In RA, there is expansion and thickening of membrane – fibroblast expansion and membrane inflammation
- leukocytes, monocytes invade thin membrane and cause swelling
- This impairs joint movement
- Synovial fluid is filled with leukocytes, so becomes thickened
- Fibroblasts no longer produce lubricin properly
- Swelling, pain, difficulty in movement
- Inflammatory environment: cytokines and destructive enzymes form osteoclasts – bone erosion and irreversible loss of cartilage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the types of arthritis and their key features?

A
  1. rheumatoid arthritis
    - symmetrical
  2. psoriatic arthritis
    - asymmetric
  3. Ankylosing spondylitis
    - inflammation of axial skeleton
  4. osteoarthritis
    - ageing disease, caused by damage to cartilage

all include overactivity of immune system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how can different arthritis be treated?

A

OA = steroids and hip replacement

RA = DMARDs to block TNFa, joint replacement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how is osteoarthritis different to RA?

A

Osteoarthritis:
- unclear if damage to joint causes localised inflammation, orif localised inflammation cause damage
- Loss of cartilage first, then bone changes
- OA gets worse with movement

Whereas inflammatory arthritis is characterised by synovial inflammation which then causes damage to bone/cartilage
- RA improves with movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the risk factors for RA?

A
  • increasing age (but not an age-related disease)
  • female sex (3:1)
  • genetic component - heritability is 53-68%
  • environmental risk factors e.g. smoking, dust/silica, P. gingivalis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the genetic predispositions for RA?

A

HLA-DRB1 gene variants - “Shared epitope”

Variants or single nucleotide polymorphisms (SNP) in:
- Protein Tyrosine Phosphatase 22 (PTPN22)
- CTLA4
- STAT4
- IL-6
- NF-Kb
- PAD enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

does the genetic risk encompass the entire cause of RA?

A

There is a genetic component, but this doesn’t explain entirety of risk
- Can have genetic risk factor and not get disease, or may not have any gene risk factor but can get disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is rheumatoid factor (RF)?

A

autoantibodies that recognize the Fc portion of immunoglobulin G molecules
- RFs have numerous causes in addition to RA and therefore have limited specificity for RA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

is RF good for RA diagnosis?

A

no:
- Found in RA patients, but also seen in other diseases and even in healthy people
- RF is not specific to RA, but most RA patients have RF
25% healthy 50 year olds have RF – harmful but not causal
- People with RF may not get RA, but can exacerbate RA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are ACPAs in RA?

A

autoantibodies to citrullinated protein/peptide autoantigens
- ACPA is only seen in RA
- But not all RA patients have ACPA: ACPA+ and ACPA- RA may be different diseases
- ACPA are causal antibodies in some patients, while other patients may have other causes
- ACPA can be present in family members of RA patients before they have symptoms – should we treat people who have ACPA and who may be at risk of RA?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how are peptides citrullinated?

A
  • cyclic citrullinated peptide is where arginine is converted to citrulline
  • this can happen to any protein - citrullination is non-specific
  • This occurs via PAD enzymes
  • SNPs in PAD can cover RA risk
  • P gingivalis produces PAD enzyme – this is how the pathogen can generate CCPs which lead to autoantibody disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

is ACPA more specific to RA than RF?

A

yes:
- The anticyclic citrullinated peptide (anti-CCP) assay broadly detects antibodies against citrullinated proteins (ACPAs) and has high specificity and excellent sensitivity in RA
- Anti-CCP/ACPAs precede the onset of clinical RA and are associated with more severe disease, making them useful as diagnostic and prognostic tools

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what therapy is currently useful in RA?

A

anti-TNF to dampen down inflammatory responses against the synovium
- but, toxic effects as patient becomes more susceptible to pathogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what are the 3 categories of mouse arthritis models?

A
  1. True autoimmune models
    - collagen-induced arthritis (CIA)
  2. Antibody transfer (cheat autoimmune) models
    - KBxN serum transfer
  3. inflammatory models
    - TNF dARE
22
Q

what is the CIA RA model?

A

Collagen-induced arthritis
- Classical break of tolerance
- This model is a true AI model as it is induced by break of tolerance
- Immune response against self-antigen
- Used to test most RA drugs = gold standard model
- not perfect recapitulation of RA however

23
Q

how is the CIA model induced?

A
  1. 10 week old mice immunised with heterologous bovine type II collagen in complete Freund’s adjuvant
  2. this induces an immune response in the mouse against the articular cartilage collagen
  3. 3 weeks later, mice are given second collagen injection, lacking Freund’s
  4. after second injection, some mice have inflammation at joint - AI response with autoantibodies against articular collagen
    - wait 6 weeks, and some will show arthritis, which may be in one joint or all joints
24
Q

what type of collagen is injected into the CIA mice?

A

heterologous type II collagen (C-II)
- Heterologous collagen derived from cow (bovine) – similar to mouse collagen, but not exactly the same
- If giving mouse collagen, it wouldn’t be recognised as foreign so no immune response would be mounted
- Need to give cow collagen as it is foreign enough to be recognised and be similar enough to mouse peptide to induce autoimmunity against mouse collagen in joint

25
Q

what is Freund’s adjuvant?

A

CFA = mineral oil emulsion containing heat-inactivated M.tuberculosis
- provides danger signal to immune system

26
Q

why is Freund’s adjuvant used in CIA?

A

the mouse immune system sees TB bacteria and mounts an immune response to it, in conjunction with recognising the foreign type II collagen which it interprets and dangerous due to the TB
- generates autoantibodies to collagen

27
Q

what strain of mice does CIA work in?

A

Susceptibility to CIA is strongly associated with major histocompatibility complex class II genes – therefore this model only works in certain strains of mice, specifically DBA1 mice
- Break of tolerance is hard to achieve, only works in certain strains of mice

28
Q

what pathological symptoms are induced in the CIA mice?

A

Antibodies to type II collagen (found specifically in cartilage) result in an inflammatory response directed towards the joint.
- Infiltration of the synovium with granulocytes and mononuclear cells
- Aggressive pannus formation resulting in cartilage degradation and erosion of bone
- pannus = inflammed and invasive synovium, causing bone damage
- Pro-inflammatory cytokines including tumor necrosis factor alpha (TNF-α) are increased in CIA similar to in RA.

29
Q

what are the limitations of CIA?

A
  • need a specific strain of mouse which are not always accessible
  • can take a long time to perform and is tricky to induce
  • there is a low arthritis incidence in the mice: 40-70%
  • there is variable severity of arthritis - non-standardised
  • variable time arthritis of onset from 1 day to 3 weeks
  • need large sample cohort for experiments for statistical power
30
Q

how can swelling in mice be measured?

A

Can see the swelling in feet which can be measured with callipers

Can also measure autoantibody titer

31
Q

what is the KBxN antibody-induced serum transfer arthritis model?

A

Rather than induce the mouse to break tolerance, we provide autoantibodies to the mouse and see inflammation
- the response is short-lived as the autoantibodies are cleared
- but can be extended by repeated injection

32
Q

what are the advantages of the KBxN serum transfer model?

A
  • Can be induced on most mouse strains such as C57BL/6 mice, so widely used
  • All mice get arthritis to similar degree the same after – can plan treatment easily, use smaller sample size
  • once antibodies are given, mice develop arthritis one day later - less variability
  • Rather than large cohort with staggered onset and variability, can use smaller cohort which have same level of arthritis and compare genes or drugs
  • transient so can show disease resolution
33
Q

what are the limitations of the KBxN serum transfer model?

A

Doesn’t involve T cells as antibodies are superficially added, so it bypasses adaptive immunity and only looks at innate immunity in the disease

transient, so not good for looking at chronic bone damage

34
Q

how is the KBxN mouse generated?

A

Mice expressing the T cell receptor transgene KRN-B/6 (which recognises an epitope of bovine RNase) are bred with NOD mice that express the MHC class II molecule Ag7.

NOD = non-obese diabetic mouse

Cross produces KBxN mouse - this is not the cheat mouse! this is a classic break of tolerance as it produces autoantibodies endogenously - true AI model

35
Q

what are the features of the KBxN mouse?

A

These mice naturally and systemically develop autoantibodies to glucose 6 phosphate isomerase (GPI), expressed by all cells in body
- These mice have arthritis and inflammatory bowel disease
- symmetrical arthritis, similar to RA
- induced by certain HLA MHCII Ag7 allele
- different inflammatory infiltrates compared to human

36
Q

how is the KBxN serum transfer performed?

A

Take blood/sera from KBxN mice and inject into WT mice of any strain
- this could induce arthritis in those mice within 1/2 days and last for a few weeks
- this is the cheat mouse, as autoantibodies are being administered, not naturally generated

37
Q

why is KBxN serum transfer sometimes preferred over CIA?

A

This is useful if a C57BL/6 mouse has a K/O of interest but can’t be injected with CIA as it lacks the MHC susceptibility

38
Q

what are the symptoms that are induced in KBxN serum transfer mice?

A

Transient disease: 2-3 weeks duration – can study induction and resolution of inflammation
- Punctate bone erosions, swelling from infiltrating leukocytes
- Requires complement components, Fc receptors and neutrophils - predominantly a neutrophil driven disease, not requiring T or B cells

39
Q

what is the TNF-dARE model?

A

Autoinflammation model
- Nothing to do with immune system
- Underlines the importance of TNF in RA
- Anti-TNFa therapy developed from this model

40
Q

what is the TNF dARE mouse?

A

TNF gene is replaced with the TNF dARE transgene:
- Deletion of the ARE, 3’ UTR regulatory element of TNF

41
Q

what is ARE?

A

AU-rich elements in RNA
- important for RNA stability

42
Q

how is RNA stability normally induced?

A

RNA stability is regulated in different ways, and ARE is an important way
- Stable mRNA is circularised – interaction of eIF (eukaryotic initiation factor) with PABP (polyA binding protein)
- PABP is bound to the mRNA polyA tail (3’end)
- eIF at 5’ binds to PABP at 3’ which causes circularisation
- Circularisation prevents access of mRNA decay enzymes – increases stability
- Protein can be produced from stable mRNA

43
Q

what happens to RNA upon ARE?

A

In unstable mRNA, there is no eIF, so no binding to the polyA tail via PABP
- There is an AU-rich element (ARE) in mRNA, where ARE-BP (ARE binding protein) can bind to prevent circularisation - mRNA becomes unstable
- Decay enzymes can degrade the 5’ mRNA end quickly
- ARE-BP recruits PARN (polyA ribonuclease) which removes the polyA tail: mRNA decay enzymes can attack at the 3’ end
- results in unstable mRNA which cannot be translated

44
Q

why is RNA stability of TNF via ARE crucial?

A

In presence of ARE, TNF RNA becomes very unstable, so is produced and degraded quickly
- So TNF cytokine cannot be made
- This enables tight regulation of TNFa to avoid excessive inflammation – quick degradation if needed
- Proinflammatory cytokines tend to be regulated in this way as they have an AU rich element

45
Q

what happens to TNF in the TNF dARE model?

A
  • There is deletion of the ARE in the TNFa gene
  • Previously unstable TNF gene (mRNA is rapidly degraded) is replaced with stable TNF dARE gene which lacks ARE, therefore mRNA is stable and translated into TNF protein, which is inflammatory
  • TNFa mRNA becomes stable in the mouse model – systemic inflammation via TNFa
46
Q

what are the symptoms in the TNF dARE mice?

A

Increased TNF expression leads to development of inflammatory polyarthritis and inflammatory bowel disease (IBD)
- systemic inflammation, with arthritis in cartilage due to invading synovium
- IBD detectable by histology at 3 weeks old
- Arthritis is detectable by histology at 5 weeks old

47
Q

how persistent is the TNF dARE mode?

A

This disease is persistent, not transient
- Occurs at birth but is progressive with age
- Bone erosion where tendons join bone (entheses) - this isn’t seen in RA, more like AS
- Little swelling
- Myeloid cell and fibroblast-driven disease, little T and B cell involvement

48
Q

how could ARE be targeted in RA?

A

new study using tristetraprolin (TTP) which binds to ARE elements of mRNA
- it then recruits deadenylases which shorten the polyA tail to promote rapid degradation of mRNA, leading to reduced protein production

active TTP = dephosphorylated
inactive = phosphorylated

49
Q

how was TTP studied in RA?

A

KBxN serum transfer arthritis in genetically modified mouse where TTP was always active due to inability to be phosphorylated (these sites were removed) - its gene was modified
- compared to WT mouse treated/not treated with dephosphorylating agents
- genetically modified mouse was protected from inflammation

50
Q

what is the SCID model of cartilage destruction?

A

simplified in vivo model with just one cell type
- SCID mouse lacks mature T and B cells - ideal for accepting grafts from other organisms without rejection
- human synovial fibroblasts embedded in sponge are combined with human articular cartilage under the kidney capsule of the mouse, which is highly vascularised and can maintain engrafted tissue with nutrition
- graft is inserted when mice are under anaesthesia and left for 4 weeks

51
Q

what is the role of the fibroblasts in the SCID model?

A
  • synovial fibroblasts from RA patients are pathogenic and invade the cartilage (healthy controls do not)
  • shows that fibroblasts alone can be destructive and are a good treatment target
  • enables study of fibroblasts in isolation without complication of other cell types but in a physiological environment
52
Q

once arthritis is induced in a mouse, how is it measured?

A
  1. clinical scoring
    - swollen joint count, degree of swelling with callipers, joint deformity, gait, weight gain, mouse behaviour
    - happens when mouse is live

these are after euthanasia:
2. microCT - detect bone erosion
3. histology e.g. H&E stain of cartilage
4. flow cytometry analysis of synovial infiltrate